04th week of 2021 patent applcation highlights part 24 |
Patent application number | Title | Published |
20210024588 | ANTIBACTERIAL METHOD | 2021-01-28 |
20210024589 | NEISSERIA MENINGITIDIS COMPOSITION AND METHODS THEREOF | 2021-01-28 |
20210024590 | PEPCON PROTEOMICS STANDARDS AND METHODS OF USE | 2021-01-28 |
20210024591 | TARGETING G3BP AGGREGATION TO PREVENT NEURODEGENERATION | 2021-01-28 |
20210024592 | Vip3 INTERACTING POLYPEPTIDES AND METHODS FOR IDENTIFYING INSECTICIDAL AGENTS | 2021-01-28 |
20210024593 | MODIFIED HEAT SHOCK PROTEINS | 2021-01-28 |
20210024594 | Therapeutic Agent for Psoriasis | 2021-01-28 |
20210024595 | DISRUPTION OF THE WAVE3 PROTEIN COMPLEX FOR SUPPRESSION OF INVASION AND METASTASIS | 2021-01-28 |
20210024596 | PRO-COAGULANT HISTONES | 2021-01-28 |
20210024597 | TREATMENT OF MYOTONIC DYSTROPHY | 2021-01-28 |
20210024598 | NOVEL RECOMBINANT BI-FUNCTIONAL FUSION PROTEIN AND PREPARATION AND APPLICATION THEREFOR | 2021-01-28 |
20210024599 | MUTANT HSP70i TO PREVENT AUTOIMMUNE DISEASE | 2021-01-28 |
20210024600 | RECOMBINANT FILAGGRIN POLYPEPTIDES FOR CELL IMPORTATION | 2021-01-28 |
20210024601 | INTERLEUKIN-2 AGENTS AND USES THEREOF | 2021-01-28 |
20210024602 | IL-2 Conjugates | 2021-01-28 |
20210024603 | ANTIGENIC PEPTIDES DERIVING FROM UROCORTIN 3 AND USES THEREOF FOR THE DIAGNOSIS AND TREATMENT OF TYPE 1 DIABETES | 2021-01-28 |
20210024604 | NOVEL INSULIN DERIVATIVES | 2021-01-28 |
20210024605 | CYCLIC PEPTIDE ANALOGS OF MELANOCORTIN AND AMANITIN AND METHODS OF MAKING SUCH | 2021-01-28 |
20210024606 | NUCLEASE-MEDIATED REGULATION OF GENE EXPRESSION | 2021-01-28 |
20210024607 | EXPRESSION VECTORS FOR CHIMERIC ENGULFMENT RECEPTORS, GENETICALLY MODIFIED HOST CELLS, AND USES THEREOF | 2021-01-28 |
20210024608 | NKG2D CHIMERIC ANTIGEN RECEPTORS | 2021-01-28 |
20210024609 | NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST ESOPHAGEAL CANCER AND OTHER CANCERS | 2021-01-28 |
20210024610 | HER2-TARGETING ANTIGEN BINDING MOLECULES COMPRISING 4-1BBL | 2021-01-28 |
20210024611 | Advanced Avatar Dendritic Cells | 2021-01-28 |
20210024612 | PD-L1 BINDING FIBRONECTIN TYPE III DOMAINS | 2021-01-28 |
20210024613 | SERPIN FUSION POLYPEPTIDES AND METHODS OF USE THEREOF | 2021-01-28 |
20210024614 | Aldehyde Tags, Uses Thereof in Site-Specific Protein Modification | 2021-01-28 |
20210024615 | CHIMERIC FC RECEPTOR BINDING PROTEINS AND USES THEREOF | 2021-01-28 |
20210024616 | Method for Purifying Antibodies from Raw Milk | 2021-01-28 |
20210024617 | HUMAN ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN | 2021-01-28 |
20210024618 | OPTIMIZED CROSSLINKERS FOR TRAPPING A TARGET ON A SUBSTRATE | 2021-01-28 |
20210024619 | IMMUNOGENIC PEPTIDE AGAINST GROUP A STREPTOCOCCUS | 2021-01-28 |
20210024620 | Methods of Treating Antibody-Mediated Disorders with FcRn Antagonists | 2021-01-28 |
20210024621 | ANTIBODY FRAGMENT DEGRADING AND REMOVING ABNORMAL TDP-43 | 2021-01-28 |
20210024622 | ANTI-TAU ANTIBODIES AND USES THEREOF | 2021-01-28 |
20210024623 | ANTI-BAG3 ANTIBODIES AS THERAPEUTIC REAGENT IN CARDIOVASCULAR DISEASE | 2021-01-28 |
20210024624 | FUSION PROTEINS FOR OPHTHALMOLOGY WITH INCREASED EYE RETENTION | 2021-01-28 |
20210024625 | Anti-PfRH5 Antibodies and Antigen-Binding Fragments Thereof | 2021-01-28 |
20210024626 | HUMAN IL-23 ANTIGEN BINDING PROTEINS | 2021-01-28 |
20210024627 | IL-1BETA NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES | 2021-01-28 |
20210024628 | METHODS FOR MODULATING INNATE LYMPHOID CELL ACTIVITY, ANTIBODY DRUG CONJUGATES AND USES IN THERAPY | 2021-01-28 |
20210024629 | BINDING MOLECULES SPECIFIC FOR ASCT2 AND USES THEREOF | 2021-01-28 |
20210024630 | GUIDANCE AND NAVIGATION CONTROL PROTEINS AND METHOD OF MAKING AND USING THEREOF | 2021-01-28 |
20210024631 | BI-FUNCTIONAL PROTEINS AND CONSTRUCTION THEREOF | 2021-01-28 |
20210024632 | RECOMBINANT SINGLE CHAIN IMMUNOGLOBULINS | 2021-01-28 |
20210024633 | METHODS OF TREATING CANCER IN SUBJECTS HAVING DYSREGULATED LYMPHATIC SYSTEMS | 2021-01-28 |
20210024634 | METHODS FOR PREDICTING AND ENHANCING THERAPEUTIC BENEFIT FROM CHECKPOINT INHIBITORS IN CANCER | 2021-01-28 |
20210024635 | ANTI-WT1/HLA-SPECIFIC ANTIBODIES | 2021-01-28 |
20210024637 | CLEC9A BINDING AGENTS AND USE THEREOF | 2021-01-28 |
20210024638 | ANTI-EGFR/ANTI-4-1BB BISPECIFIC ANTIBODY AND USE THEREOF | 2021-01-28 |
20210024639 | METHODS FOR PROMOTING PANCREATIC ISLET CELL GROWTH | 2021-01-28 |
20210024640 | CANCER TREATMENT USING ANTIBODIES THAT BIND HUMAN CD134 (OX40) RECEPTOR | 2021-01-28 |
20210024641 | ANTI-CD40 ANTIBODIES AND USES THEREOF | 2021-01-28 |
20210024642 | ANTI-CD40 ANTIBODY AND THEIR USES | 2021-01-28 |
20210024643 | METHOD FOR TREATING JOINT DAMAGE | 2021-01-28 |
20210024644 | N-CADHERIN BINDING MOLECULES AND USES THEREOF | 2021-01-28 |
20210024645 | CD38 PROTEIN ANTIBODY AND APPLICATION THEREOF | 2021-01-28 |
20210024646 | TARGETED CD73 ANTIBODY AND ANTIBODY-DRUG CONJUGATE, AND PREPARATION METHOD THEREFOR AND USES THEREOF | 2021-01-28 |
20210024647 | BISPECIFIC ANTI-CD37 ANTIBODIES, MONOCLONAL ANTI-CD37 ANTIBODIES AND METHODS OF USE THEREOF | 2021-01-28 |
20210024648 | MODIFIED PSEUDOMONAS EXOTOXIN A | 2021-01-28 |
20210024649 | Methods and Compositions for Antibody and Antibody-loaded Dendritic Cell Mediated Therapy | 2021-01-28 |
20210024650 | ANTI-HER2/ANTI-4-1BB BISPECIFIC ANTIBODY AND USE THEREOF | 2021-01-28 |
20210024651 | HER3 ANTIGEN-BINDING MOLECULES | 2021-01-28 |
20210024652 | Compositions and Methods to Regulate Renalase in the Treatment of Cancer | 2021-01-28 |
20210024653 | Antibodies to Symmetrically Dimethylated Arginine Analytes and Use Thereof | 2021-01-28 |
20210024654 | Bispecific CD33 and CD3 Binding Proteins | 2021-01-28 |
20210024655 | TARGET RECOGNITION MOTIFS AND USES THEREOF | 2021-01-28 |
20210024656 | HYPROMELLOSE ACETATE SUCCINATE POWDER EXCELLENT IN DISSOLVED STATE AND PRODUCTION METHOD THEREOF, AND PRODUCTION METHODS FOR COMPOSITION FOR SOLID DISPERSION, COATING COMPOSITION, DRUG-CONTAINING PARTICLE, AND SOLID PREPARATION | 2021-01-28 |
20210024657 | COMPOSITE AND INFRARED ABSORBER, THIN FILM, PHOTOELECTRIC DEVICE, AND ELECTRONIC DEVICE INCLUDING SAME | 2021-01-28 |
20210024658 | METHOD FOR CO-PRODUCTION OF GELLING AND EMULSIFYING PECTINS FROM CHICORY/JERUSALEM ARTICHOKE PULP | 2021-01-28 |
20210024659 | NOVEL REACTIVE ALGINIC ACID DERIVATIVES | 2021-01-28 |
20210024660 | Methods for Scale-Up From a Pilot Plant to a Larger Production Facility | 2021-01-28 |
20210024661 | ACRYLIC POLYMERS, AQUEOUS POLYMERIC DISPERSIONS PREPARED THEREFROM, AND CURABLE FILM-FORMING COMPOSITIONS PREPARED THEREFROM | 2021-01-28 |
20210024662 | A ZIEGLER-NATTA CATALYST SYSTEM WITH SELF-EXTINGUISHING PROPERTIES SUITABLE FOR OLEFIN POLYMERIZATION | 2021-01-28 |
20210024663 | METHOD FOR DEODORIZING HYDROGENATED PETROLEUM RESIN, AND METHOD FOR PRODUCING HYDROGENATED PETROLEUM RESIN | 2021-01-28 |
20210024664 | MOLDED ARTICLE HAVING COOLING-LIQUID-CONTACT SURFACE | 2021-01-28 |
20210024665 | COMPOUND CONTAINING UNSATURATED DOUBLE BOND, OXYGEN ABSORBER COMPRISING SAME, AND RESIN COMPOSITION | 2021-01-28 |
20210024666 | POLYBUTADIENE, PRODUCTION AND USE THEREOF | 2021-01-28 |
20210024667 | Ethylene-Vinyl Acetate Copolymer And Preparation Method Thereof | 2021-01-28 |
20210024668 | Propylene-Based Polymer Additives for Improved Tire Tread Performance | 2021-01-28 |
20210024669 | PROCESS FOR OBTAINING LOW VOLATILE PLASTOMERS | 2021-01-28 |
20210024670 | METHOD TO PREPARE ETHYLENE COPOLYMERS | 2021-01-28 |
20210024671 | Novel Medium Density Polyethylene Compositions | 2021-01-28 |
20210024672 | POLYMER, ION-EXCHANGE MEMBRANE, AND STRUCTURE-ENHANCED MEMBRANE EMPLOYING THE SAME | 2021-01-28 |
20210024673 | PROCESS FOR THE PREPARATION OF A VINYLIDENE CHLORIDE POLYMER | 2021-01-28 |
20210024674 | POLYMER COMPOUND, COMPOSITION, INSULATING LAYER, AND ORGANIC THIN FILM TRANSISTOR | 2021-01-28 |
20210024675 | OPTICAL LENS | 2021-01-28 |
20210024676 | METHOD FOR PRODUCING HYDROGENATED PETROLEUM RESIN | 2021-01-28 |
20210024677 | Denture Material Having Anti-Microbial Properties | 2021-01-28 |
20210024678 | METHOD FOR PREPARING GRAFT COPOLYMER AND GRAFT COPOLYMER | 2021-01-28 |
20210024679 | CATALYST SYSTEM FOR URETDIONE DISPERSIONS | 2021-01-28 |
20210024680 | AQUEOUS URETDIONE GROUP-CONTAINING COMPOSITIONS AND METHOD FOR PRODUCING SAME | 2021-01-28 |
20210024681 | METHOD FOR PRODUCING POLYURETHANE SOFT FOAMS | 2021-01-28 |
20210024682 | PHOTOCURABLE RESIN COMPOSITION | 2021-01-28 |
20210024683 | THIXOTROPIC RHEOLOGY MODIFYING AGENT COMPOSITIONS | 2021-01-28 |
20210024684 | Compositions for Use in Impregnation of Paper Bushings | 2021-01-28 |
20210024685 | STABLE POLYCYCLOOLEFIN POLYMER AND INORGANIC NANOPARTICLE COMPOSITIONS AS OPTICAL MATERIALS | 2021-01-28 |
20210024686 | POLY(GLYCEROL SEBACATE)-INTERLEUKIN INHIBITOR COPOLYMERS AND METHODS OF MAKING AND USE | 2021-01-28 |
20210024687 | AROMATIC LIQUID CRYSTAL POLYESTER, AROMATIC LIQUID CRYSTAL POLYESTER COMPOSITION, AND MOLDED ARTICLE | 2021-01-28 |
20210024688 | COPOLYESTERS DERIVED FROM ALIPHATIC GLYCOLS, AROMATIC DICARBOXYLIC ACIDS AND POLY(ALKYLENE-OXIDES) AND FILMS MADE THEREFROM | 2021-01-28 |